{"data":{"id":"us/21-cfr-355.55","jurisdiction":"us","citation":"21 CFR 355.55","heading":"Principal display panel of all fluoride rinse drug products.","body":"In addition to the statement of identity required in § 355.50, the following statement shall be prominently placed on the principal display panel: “IMPORTANT: Read directions for proper use.”","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 355—ANTICARIES DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE","Subpart C—Labeling"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"b41283a848d95bf9cd26180f364a03826c7e35509c6a2ad49cd7bcb6087164ad","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-355.50","next":"us/21-cfr-355.60"},"notice":"GroundRules: Original legal text. Not legal advice."}